{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:47:19Z","timestamp":1777582039014,"version":"3.51.4"},"reference-count":43,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2019,8,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Portal vein thrombosis (PVT) is a common complication of endstage\nhepatocellular carcinoma (HCC).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The aim of our study was to evaluate the role of Homocysteine (Hcy) in HCC patient with\nPVT. Hcy is a sulphur amino-acid involved in two pathways, trans-sulphuration and\nremethylation, that involve vitamins B6, B12 and folates.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We recruited 54 patients with HCC and PVT, 60 patients with HCC and\nwithout PVT and 60 control subjects. We measured serum levels of Hcy, folate, vitamins\nB6 and B12.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The comparison between HCC patients with PVT versus HCC without PVT\nwas shown that mean values of Hcy were 6.4 nmol\/L (p&lt;0.0073) higher, LDL cholesterol\nwere 4.8 mg\/dl (p&lt;0.0079) lower, vitamin B6 were 4.6 nmol\/L(p=0.0544) lower, vitamins\nB 12 were 22.1 pg\/ml (p=0.0001) lower.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>High serum levels of Hcy are an established thrombotic risk factor in the\ngeneral population. We found significantly higher levels of Hcy in HCC patients with PVT\nversus both HCC patients without PVT and controls.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524019666190610120416","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T05:34:00Z","timestamp":1560317640000},"page":"532-538","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis"],"prefix":"10.2174","volume":"19","author":[{"given":"Saverio","family":"Latteri","sequence":"first","affiliation":[{"name":"Department of Medical, Surgical Sciences and Advanced Technologies \"G.F. Ingrassia\", University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Malaguarnera","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Science, University of Catania, Catania 95123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito Emanuele","family":"Catania","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical Sciences and Advanced Technologies \"G.F. Ingrassia\", University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"La Greca","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Systemic Diseases, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Bertino","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Systemic Diseases, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Maria","family":"Borz\u00ec","sequence":"additional","affiliation":[{"name":"Research Centre \"The Great Senescence\", University of Catania, 95100 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Science, University of Catania, Catania 95123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Malaguarnera","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Science, University of Catania, Catania 95123, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"191497","DOI":"10.1155\/2014\/191497","volume":"2014","author":"Malaguarnera G.","year":"2014","unstructured":"Malaguarnera G.; Gagliano C.; Giordano M.; Salomone S.; Vacante M.; Bucolo C.; Caraci F.; Reibaldi M.; Drago F.; Avitabile T.; Motta M.;  Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy. BioMed Res Int 2014,2014,191497","journal-title":"BioMed Res Int"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199502023320502","volume":"332","author":"Selhub J.","year":"1995","unstructured":"Selhub J.; Jacques P.F.; Bostom A.G.;  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995,332(5),286-291","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/PL00014300","volume":"157","author":"Finkelstein J.D.","year":"1998","unstructured":"Finkelstein J.D.;  The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998,157(Suppl. 2),S40-S44","journal-title":"Eur J Pediatr"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","volume":"19","author":"Selhub J.","year":"1999","unstructured":"Selhub J.;  Homocysteine metabolism. Annu Rev Nutr 1999,19,217-246","journal-title":"Annu Rev Nutr"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/hep.24670","volume":"54","author":"Bruix J.","year":"2011","unstructured":"Bruix J.; Reig M.; Rimola J.;  Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques. Hepatology 2011,54(6),2238-2244","journal-title":"Hepatology"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.3748\/wjg.v22.i32.7289","volume":"22","author":"Chan S.L.","year":"2016","unstructured":"Chan S.L.; Chong C.C.; Chan A.W.; Poon D.M.; Chok K.S.;  Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016. World J Gastroenterol 2016,22(32),7289-7300","journal-title":"World J Gastroenterol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12012-009-9042-6","volume":"9","author":"Joseph J.","year":"2009","unstructured":"Joseph J.; Handy D.E.; Loscalzo J.;  Quo vadis: whither homocysteine research? Cardiovasc Toxicol 2009,9(2),53-63","journal-title":"Cardiovasc Toxicol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature05919","volume":"447","author":"Feinberg A.P.","year":"2007","unstructured":"Feinberg A.P.;  Phenotypic plasticity and the epigenetics of human disease. Nature 2007,447(7143),433-440","journal-title":"Nature"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"25380","DOI":"10.1074\/jbc.272.40.25380","volume":"272","author":"Wang H.","year":"1997","unstructured":"Wang H.; Yoshizumi M.; Lai K.;  Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 1997,272(40),25380-25385","journal-title":"J Biol Chem"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1386-6346(00)00119-4","volume":"20","author":"Bosy-Westphal A.","year":"2001","unstructured":"Bosy-Westphal A.; Petersen S.; Hinrichsen H.; Czech N.J.; M\u00fcller M.;  Increased plasma homocysteine in liver cirrhosis. Hepatol Res 2001,20(1),28-38","journal-title":"Hepatol Res"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1074\/jbc.M004124200","volume":"276","author":"Undas A.","year":"2001","unstructured":"Undas A.; Williams E.B.; Butenas S.; Orfeo T.; Mann K.G.;  Homocysteine inhibits inactivation of factor Va by activated protein C. J Biol Chem 2001,276(6),4389-4397","journal-title":"J Biol Chem"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","volume":"80","author":"den Heijer M.","year":"1998","unstructured":"den Heijer M.; Rosendaal F.R.; Blom H.J.; Gerrits W.B.; Bos G.M.;  Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998,80(6),874-877","journal-title":"Thromb Haemost"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.ATV.18.3.356","volume":"18","author":"den Heijer M.","year":"1998","unstructured":"den Heijer M.; Brouwer I.A.; Bos G.M.;  Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol 1998,18(3),356-361","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40520-016-0653-z","volume":"29","author":"Malaguarnera G.","year":"2017","unstructured":"Malaguarnera G.; Catania V.E.; Francaviglia A.;  Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis. Aging Clin Exp Res 2017,29(Suppl. 1),185-190","journal-title":"Aging Clin Exp Res"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0971-5851.89775","volume":"32","author":"Uccello M.","year":"2011","unstructured":"Uccello M.; Malaguarnera G.; Pelligra E.M.; Biondi A.; Basile F.; Motta M.;  Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma. Indian J Med Paediatr Oncol 2011,32(2),71-75","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4254\/wjh.v10.i6.448","volume":"10","author":"Bertino G.","year":"2018","unstructured":"Bertino G.; Malaguarnera G.; Frazzetto E.;  Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions. World J Hepatol 2018,10(6),448-451","journal-title":"World J Hepatol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2007.01.002","volume":"44","author":"Gatt A.","year":"2007","unstructured":"Gatt A.; Makris M.;  Hyperhomocysteinemia and venous thrombosis. Semin Hematol 2007,44(2),70-76","journal-title":"Semin Hematol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.STR.21.4.572","volume":"21","author":"Coull B.M.","year":"1990","unstructured":"Coull B.M.; Malinow M.R.; Beamer N.; Sexton G.; Nordt F.; de Garmo P.;  Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990,21(4),572-576","journal-title":"Stroke"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.05.046","volume":"26","author":"Vecchio M.","year":"2017","unstructured":"Vecchio M.; Gracies J.M.; Panza F.;  Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study. J Stroke Cerebrovasc Dis 2017,26(11),2536-2540","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00042737-200507000-00009","volume":"17","author":"Mangia A.","year":"2005","unstructured":"Mangia A.; Villani M.R.; Cappucci G.;  Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005,17(7),745-751","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/jsre.1996.0053","volume":"60","author":"Gayowski T.J.","year":"1996","unstructured":"Gayowski T.J.; Marino I.R.; Doyle H.R.;  A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996,60(2),333-338","journal-title":"J Surg Res"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/CEG.S172663","volume":"11","author":"Malaguarnera M.","year":"1996","unstructured":"Malaguarnera M.; Latteri S.; Bertino G.;  D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis. Clin Exp Gastroenterol 1996,11,373-380","journal-title":"Clin Exp Gastroenterol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijso.2018.11.001","volume":"15","author":"Malaguarnera M.","year":"2018","unstructured":"Malaguarnera M.; Catania V.E.; Borz\u00ec A.M.;  Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study. International Journal of Surgery Open 2018,15,60-65","journal-title":"International Journal of Surgery Open"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/00365518809167487","volume":"48","author":"Brattstr\u00f6m L.E.","year":"1988","unstructured":"Brattstr\u00f6m L.E.; Israelsson B.; Jeppsson J.O.; Hultberg B.L.;  Folic acid--an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988,48(3),215-221","journal-title":"Scand J Clin Lab Invest"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","volume":"4","author":"Omata M.","year":"2010","unstructured":"Omata M.; Lesmana L.A.; Tateishi R.;  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010,4(2),439-474","journal-title":"Hepatol Int"},{"key":"ref=26","first-page":"751","volume":"28","year":"1998","unstructured":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998,28(3),751-755","journal-title":"Hepatology"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1111\/j.1872-034X.2007.00186.x","volume":"37","author":"Daniele B.","year":"2007","unstructured":"Daniele B.; Annunziata M.; Barletta E.; Tinessa V.; Di Maio M.;  Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma. Hepatol Res 2007,37(Suppl. 2),S206-S209","journal-title":"Hepatol Res"},{"key":"ref=28","first-page":"407","volume":"3","author":"Malaguarnera G.","year":"2014","unstructured":"Malaguarnera G.; Bertino G.; Vacante M.; Malaguarnera M.;  Hepatocellular carcinoma markers in the omics era: the glycomic analysis. Hepatobiliary Surg Nutr 2014,3(6)(Suppl. 2),407-409","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1388-1981(00)00030-5","volume":"1485","author":"Lynch S.M.","year":"2000","unstructured":"Lynch S.M.; Campione A.L.; Moore M.K.;  Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta 2000,1485(1),11-22","journal-title":"Biochim Biophys Acta"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/ajcn\/77.5.1269","volume":"77","author":"Bosy-Westphal A.","year":"2003","unstructured":"Bosy-Westphal A.; Ruschmeyer M.; Czech N.;  Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr 2003,77(5),1269-1277","journal-title":"Am J Clin Nutr"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s001090050079","volume":"74","author":"C\u00f3rdoba-Porras A.","year":"1996","unstructured":"C\u00f3rdoba-Porras A.; S\u00e1nchez-Quesada J.L.; Gonz\u00e1lez-Sastre F.; Ord\u00f3\u00f1ez-Llanos J.; Blanco-Vaca F.;  Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinemia. J Mol Med (Berl) 1996,74(12),771-776","journal-title":"J Mol Med (Berl)"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI11596","volume":"107","author":"Werstuck G.H.","year":"2001","unstructured":"Werstuck G.H.; Lentz S.R.; Dayal S.;  Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001,107(10),1263-1273","journal-title":"J Clin Invest"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","volume":"9","author":"Bestor T.H.","year":"2000","unstructured":"Bestor T.H.;  The DNA methyltransferases of mammals. Hum Mol Genet 2000,9(16),2395-2402","journal-title":"Hum Mol Genet"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","volume":"31","author":"Klose R.J.","year":"2006","unstructured":"Klose R.J.; Bird A.P.;  Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006,31(2),89-97","journal-title":"Trends Biochem Sci"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4254\/wjh.v8.i13.573","volume":"8","author":"Rapisarda V.","year":"2016","unstructured":"Rapisarda V.; Loreto C.; Malaguarnera M.;  Hepatocellular carcinoma and the risk of occupational exposure. World J Hepatol 2016,8(13),573-590","journal-title":"World J Hepatol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40477-017-0252-7","volume":"20","author":"Latteri S.","year":"2017","unstructured":"Latteri S.; Malaguarnera G.; Mannino M.;  Ultrasound as point of care in management of polytrauma and its complication. J Ultrasound 2017,20(2),171-177","journal-title":"J Ultrasound"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/biomedicines6010024","volume":"6","author":"Latteri S.","year":"2018","unstructured":"Latteri S.; Catania V.E.; Malaguarnera G.;  Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer. Biomedicines 2018,6(1),24","journal-title":"Biomedicines"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/clc.4960261204","volume":"26","author":"Gauthier G.M.","year":"2003","unstructured":"Gauthier G.M.; Keevil J.G.; McBride P.E.;  The association of homocysteine and coronary artery disease. Clin Cardiol 2003,26(12),563-568","journal-title":"Clin Cardiol"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"Selhub J.","year":"1993","unstructured":"Selhub J.; Jacques P.F.; Wilson P.W.; Rush D.; Rosenberg I.H.;  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993,270(22),2693-2698","journal-title":"JAMA"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1572-0241.2003.07160.x","volume":"98","author":"Saibeni S.","year":"2003","unstructured":"Saibeni S.; Cattaneo M.; Vecchi M.;  Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 2003,98(1),112-117","journal-title":"Am J Gastroenterol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1054\/mehy.1999.1032","volume":"55","author":"McCarty M.F.","year":"2000","unstructured":"McCarty M.F.;  Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypotheses 2000,55(4),289-293","journal-title":"Med Hypotheses"},{"key":"ref=42","first-page":"e5943","volume":"12","author":"Uccello M","year":"2012","unstructured":"Uccello M; Malaguarnera G; Corriere T; Biondi A; Basile F; Malaguarnera M;   Risk of hepatocellular carcinoma in workers exposed to chemicals 2012,12(10 HCC),e5943","journal-title":"Risk of hepatocellular carcinoma in workers exposed to chemicals"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"Welch G.N.","year":"1998","unstructured":"Welch G.N.; Loscalzo J.;  Homocysteine and atherothrombosis. N Engl J Med 1998,338(15),1042-1050","journal-title":"N Engl J Med"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T15:00:07Z","timestamp":1576854007000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172446\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524019666190610120416","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}